26th November 2021
Plenary 1 Prostate Cancer  
0800 - 0815 UAA Lecture :
Role of PSMA for Primary Staging
Renu Eapen
0820 - 0835 Focal Therapy for Localized Prostate Cancer – Is It Ready for Primetime? Jeremy Grummet
0840 – 0905 MUC@‘30:
Laparoscopic Prostatectomy is Superior to Robotic-assisted Surgery
[Debate]
Han Pei Kwong
Noor Ashani Md Yusoff
0910 – 0925 USANZ Lecture :
Best Treatment Sequence for mCRPC in the Era of Checkpoint and PARP Inhibitors
Matthew Roberts
0925 – 0935 Introductory Speech and Montage
by Ngoo Kay Seong and Arun Arunasalam
 
0935 – 1005
Breakfast Symposium 1
by Johnson & Johnson Sdn Bhd
 
1010 – 1040
Breakfast  Symposium 2
by Eisai (M) Sdn Bhd
 
Plenary 2 Paediatrics  
1045 – 1100

KUA Lecture
Paediatric Urolithiasis – Differences in Approach compared to Adults

Lee Sang Don 
1105 – 1120 SLAUS Lecture
Undescended Testis: To Explore or Not to Explore
Neville D Perera
1125 - 1140 SUA Lecture
Functional Voiding Disorders – Transitioning from Childhood to Adulthood
Ng Lay Guat
1145 - 1200 MUC@‘30:
30 Years of Hypospadias Repair: Do We Now Have a Consensus?
Mohamed Ashraf
Mohamed Daud
1210 – 1250
Lunch Symposium 1
by Abbvie Sdn Bhd
 
1255 – 1335
Lunch Symposium 2
by Astellas Pharma (M) Sdn Bhd
 
1335 - 1415 Friday Prayer Break  
Plenary 3 Urothelial Cancer  
1415 - 1430 SIU Innovators Lecture
How to Treat High Grade NMIBC if BCG is Unavailable?
Roger Li
1435 - 1450 MUC@‘30:
Role of URS before Nephroureterectomy
JR Sathiyananthan
1455– 1510 Immunotherapy in Bladder Cancer
Johan Chan
1515 – 1530 The Perfect TURBT Param Mariappan
Plenary 4 Urolithiaisis  
1540– 1555 MUC@‘30:
The Perfect Puncture for PCNL
Git Kah Ann
1600 – 1615 SIU Lecture
Metabolic Assessment for Urolithiasis: Is this a Futile Exercise?
Ranan Dasgupta
1620 – 1645 IAU MUA Session
Debate - 3cm renal stone: PCNL versus RIRS
Petrisor Geavlete
Zeng Guohua
1650 – 1705 USI Lecture
Miniaturization of PCN: Did It Change Our Approach
B Arun Kumar
1715 – 1800
Afternoon Tea Symposium 1
by Cook Asia (Malaysia) Sdn Bhd
 
27th November 2021
Plenary 1 Renal Cell Carcinoma  
0800 – 0815 Role of Lymph Node Surgery in Renal Cell Carcinoma TBC
0820 – 0835 How to Best Approach the Large Renal Cell Carcinoma Rick Catterwell
0840 – 0855 MUC@‘30:
Is There still a Role for Cytoreductive Nephrectomy?
Rohan Malek
0900 – 0915 Immunotherapy Combinations for Renal Cell Carcinoma Darren Poon Ming Chun
0920 – 0925 Video Tribute to the Late Datuk Dr Hussein Awang  
0925 - 0955
Breakfast Symposium 3
by Ipsen Pharma Singapore Pte. Ltd.




1000 - 1030
Breakfast Symposium 4
by Merck Sharpe & Dohme (M) Sdn Bhd
 
Plenary 2 BPH & Andrology  
1040 – 1055 MUC@‘30:
Management of Penile Paraffinoma
Saiful Azli Mohd Zainuddin
1100 – 1115 Update on MIS for BPH Mark Lloyd
1120 – 1135 Before the Knife: Optimising Medical Management of BPH Edwin Jonathan Aslim
1140 – 1155 MUC@ ’30:
Updates on Asian Men’s Health Report
Christopher Ho Chee Kong
1205 - 1245
Lunch Symposium 3
by Boston Scientific (M) Sdn Bhd




1250 -1330
Lunch Symposium 4
by GlaxoSmithPharmaceutical (M) Sdn Bhd
 
Plenary 3 Functional and Female Urology  
1340 – 1355 MUC@ ’30:
Artificial Urinary Sphincter for Women: Efficacy and Challenges
Lo Hwa Loon
1400 – 1415 Synthetic Midurethral Slings: Still a Viable Option? Johan Gani
1420 – 1435 EAU Lecture
Underactive Bladder: What do we Really Know?
Christopher Chapple
1440– 1455 RCPSG Lecture
On Table Gynae Referral for Iatrogenic Urological Injury – How I Would Proceed
Voula Granitsiotis
Plenary 4 Penile and Testicular Cancer  
1505 – 1520 EAU Lecture
Current Concepts of Testicular Microlithiasis and ITGCN
Pilar Laguna
1525 – 1540 NAUS Lecture
Update on LN Management of Penile Cancer
Nirmal Lamichhane
1545 – 1600 MUC@ ’30:
Ethics and Religious Issues of Sperm Banking in Malaysia
Azad Hassan Abdul Razack
Plenary 5 Covid and Urology  
1610 – 1625 TUA Lecture
Telemedicine in Urology
Bannakij Lojanapiwat
1630 – 1645 Covid Effect on Urology Duncan J Summerton
1650 – 1705 MUC@ ’30:
Vaccination in the Urology Patient
Vijayan Manogran
1715 –1745
Afternoon Tea Symposium 2
by  Zuellig Pharma (M) Sdn Bhd
 
1800 Closing remarks
by Ngoo Kay Seong and Arun Arunasalam